Exelixis Thyroid Cancer Drug Crosses Finish Line
http://www.rttnews.com/2014942/exelixis-thyroid-cancer-drug-crosses-finish-line.aspx?type=ts
Exelixis Inc.'s (EXEL: Quote) lead compound for medullary thyroid cancer, Cometriq, previously known as Cabozantinib, crossed the finish line on Thursday winning FDA approval.
Women should seek mammogram clarity via doctor's visit: medical expert
http://www.ctvnews.ca/health/women-should-seek-mammogram-clarity-via-doctor-s-visit-medical-expert-1.1055841
While recently published studies on the effectiveness of mammograms may lead to confusion among patients, individual consultations with a physician can help them make informed choices about their screening options.
What is Diabetes Mellitus?
http://timesofindia.indiatimes.com/life-style/health-fitness/health/What-is-Diabetes-Mellitus/articleshow/17425594.cms
Diabetes is a condition that is considered a lifestyle disease of the 21st century therefore it is important to know the A, B, C of diabetes.
No comments:
Post a Comment